3-iodobenzylguanidine has been researched along with Chronic Disease in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (14.89) | 18.2507 |
| 2000's | 20 (42.55) | 29.6817 |
| 2010's | 16 (34.04) | 24.3611 |
| 2020's | 4 (8.51) | 2.80 |
| Authors | Studies |
|---|---|
| Badel, JN; Bogart, E; Corradini, N; Cougnenc, O; Courbon, F; Defachelles, AS; Deley, MCL; Gambart, M; Giraudet, AL; Kolesnikov-Gauthier, H; Oudoux, A; Rault, E; Schleiermacher, G; Sevrin, F; Valteau-Couanet, D | 1 |
| Batra, V; DuBois, SG; Gikandi, A; Granger, MM; Marachelian, A; Maris, JM; Martinez, D; Matthay, KK; Park, JR; Pawel, B; Vo, KT | 1 |
| Abe, M; Fukuhara, E; Fukunami, M; Furukawa, Y; Ikeda, I; Iwasaki, Y; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Nakamura, J; Ozaki, T; Sato, Y; Seo, M; Tamaki, S; Yamada, T; Yamamoto, H | 1 |
| Doi, T; Jacobson, AF; Kadokami, T; Konno, T; Matsuo, S; Nakajima, K; Nakata, T; Yamada, T | 1 |
| De Vincentis, G; Farcomeni, A; Fedele, F; Fegatelli, DA; Frantellizzi, V; Mancone, M; Salvi, N; Scarparo, P; Verberne, HJ; Verschure, DO | 1 |
| Alfonso, G; Claudio, M; Giacomo, C; Giovanni, B; Giovanni, S; Margherita, C; Paola, P; Pierfranco, D; Riccardo, C; Stefano, M; Teresa, SM; Umberto, P | 1 |
| Abe, M; Fukuhara, E; Fukunami, M; Furukawa, Y; Ikeda-Yorifuji, I; Iwasaki, Y; Kawai, T; Kawasaki, M; Kikuchi, A; Morita, T; Nakamura, J; Seo, M; Tamaki, S; Yamada, T | 1 |
| Ichikawa, S; Iwasaki, T; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Sato, Y; Sumino, H; Toyama, T | 1 |
| Atsma, DE; Bax, JJ; Beeres, SL; Dibbets-Schneider, P; Fibbe, WE; Rodrigo, SF; Schalij, MJ; Scholte, AJ; van Ramshorst, J; Zwaginga, JJ | 1 |
| Jacobson, AF; Kasama, S; Matsui, T; Matsuo, S; Momose, M; Nakajima, K; Nakata, T; Travin, MI; Yamada, T; Yamashina, S | 1 |
| Agostini, D; Gerson, MC; Jacobson, AF; Katsikis, A; Koutelou, M; Manrique, A; Scholte, AJ; Somsen, GA; van Eck-Smit, BL; Veltman, CE; Verberne, HJ; Verschure, DO | 1 |
| Bongers, V; D'Aron, J; de Wit, TC; Hagen, PJ; Huber, K; Knoll, P; Mirzaei, S; Somsen, GA; Sonneck-Koenne, C; van Eck-Smit, BL; Verberne, HJ; Verschure, DO | 1 |
| Kasama, S; Kurabayashi, M; Toyama, T | 1 |
| Fukunami, M; Furukawa, Y; Hakui, H; Ishimi, M; Iwasaki, Y; Kawai, T; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Ozaki, T; Sakata, Y; Sato, Y; Seo, M; Takahashi, S; Tamaki, S; Yamada, T | 1 |
| Jacobson, AF; Matsuo, S; Nakajima, K; Nakata, T | 1 |
| Adachi, H; Hoshizaki, H; Kan, H; Kasama, S; Kawaguti, R; Miyaishi, Y; Ohsima, S; Toyama, T; Yamashita, E | 1 |
| Alves, CR; Mesquita, CT; Muradas, MC; Nóbrega, AC; Porto, P; Precht, BC; Souza, JS; Teixeira, JA; Ubaldo, L; Villacorta, AS; Villacorta, H | 1 |
| Fukunami, M; Hori, M; Iwasaki, Y; Masuda, M; Morita, T; Okuda, K; Okuyama, Y; Sanada, S; Tamaki, S; Tsukamoto, Y; Yamada, T; Yasui, T | 1 |
| Somsen, GA; van Eck-Smit, BL; Verberne, HJ | 1 |
| Fujimoto, S; Hisatake, S; Nakano, H; Namiki, A; Nanjo, S; Yamashina, S; Yamazaki, J; Yuzawa, H | 1 |
| Bologna, A; Casaretti, L; Conte, S; Formisano, R; Losco, T; Mattiello, G; Mosca, S; Musella, F; Parente, A; Perrone-Filardi, P; Pirozzi, E; Savarese, G | 1 |
| Beller, GA; Janardhanan, R | 1 |
| Ashino, K; Ebina, T; Inoue, T; Ishigami, T; Ishikawa, Y; Kuji, N; Matsubara, S; Minamisawa, K; Mitani, I; Ochiai, H; Oka, T; Sumita, S; Takahashi, N; Umemura, S | 1 |
| Canty, JM; Fallavollita, JA; Luisi, AJ; Suzuki, G | 1 |
| Asai, M; Fukunami, M; Hirata, A; Hoki, N; Hori, M; Kioka, H; Kumagai, K; Kusuoka, H; Makino, N; Ogita, H; Shimonagata, T; Yamada, T | 1 |
| Hirosaka, A; Ishihata, T; Komatsu, N; Maehara, K; Maruyama, Y; Onuki, N; Otani, H; Saito, T; Sato, M; Yaoita, H | 1 |
| Arimoto, T; Fukui, A; Hirono, O; Itoh, M; Kubota, I; Miyamoto, T; Nozaki, N; Okada, A; Tachibana, H; Takahashi, H; Takahashi, K; Takeishi, Y; Yamaguchi, H | 1 |
| Anastasiou-Nana, MI; Athanasoulis, T; Efentakis, S; Geramoutsos, A; Karaloizos, L; Nanas, JN; Pappa, L; Terrovitis, JV; Tsagalou, EP | 1 |
| Cobbe, SM; Martin, W; Motherwell, DW; Petrie, MC | 1 |
| Fukunami, M; Hori, M; Kioka, H; Masuda, M; Mine, T; Morita, T; Okuda, K; Tamaki, S; Tsukamoto, Y; Yamada, T | 1 |
| Agostini, D; Habraken, JB; Jacobson, AF; van Eck-Smit, BL; Verberne, HJ | 1 |
| Fujii, M; Horie, M; Nakae, I; Nishiyama, K; Ohnishi, M; Sakai, H; Tanaka, T; Tsutamoto, T; Wada, A; Yamamoto, T | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Nakazawa, M; Sato, Y; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Botvinick, EH; Chin, MC; Dae, MW; O'Connell, JW | 1 |
| Borm, JJ; de Milliano, PA; Endert, E; Lie, KI; Somsen, GA; van Royen, EA; van Vlies, B | 1 |
| Agostini, D; Amar, MH; Babatasi, G; Belin, A; Bouvard, G; Grollier, G; Lecluse, E; Potier, JC | 1 |
| Atsumi, H; Fujiwara, S; Takeishi, Y; Tomoike, H | 1 |
| Caballero, C; Cordero, J; Crespo, A; Díez, L; Rioja, M | 1 |
| Cohen-Solal, A; Dreyfus, G; Dubois, C; Esanu, Y; Gourgon, R; Logeart, D; Merlet, P; Pessione, F | 1 |
| Bandou, K; Fukuda, N; Shinohara, H; Soeki, T; Sui, O; Takeichi, N; Tamura, Y; Tanaka, H; Yui, Y | 1 |
| Asanoi, H; Fujii, N; Igawa, A; Inoue, H; Inoue, M; Nozawa, T; Tazawa, S; Yoshida, N | 1 |
| Hartikainen, J; Kettunen, R; Kuikka, J; Laitinen, T; Lakka, T; Remes, J; Simula, S | 1 |
| Ayusawa, M; Harada, K; Karasawa, K; Noto, N; Okada, T; Sumitomo, N | 1 |
| Asai, M; Asano, Y; Fukunami, M; Hirata, A; Hoki, N; Hori, M; Kumagai, K; Kusuoka, H; Ogita, H; Shimonagata, T; Yamada, T | 1 |
| Hanatani, A; Hirooka, K; Hori, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y | 1 |
| de Groot, AC; de Milliano, PA; Lie, KI; Tijssen, JG; van Eck-Smit, BL; van Zwieten, PA | 1 |
| Hasegawa, S; Hashimoto, K; Kusuoka, H; Maruyama, A; Maruyama, K; Morozumi, T; Mu, X; Nishimura, T; Paul, AK; Yamaguchi, H; Yoshioka, J | 1 |
3 review(s) available for 3-iodobenzylguanidine and Chronic Disease
| Article | Year |
|---|---|
For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis.
Topics: 3-Iodobenzylguanidine; Cause of Death; Chronic Disease; Endpoint Determination; Female; Heart Failure; Humans; Male; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Factors; Tomography, Emission-Computed, Single-Photon | 2014 |
[Clinical applications of MIBG SPECT in chronic heart failure].
Topics: 3-Iodobenzylguanidine; Chronic Disease; Heart Failure; Humans; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2012 |
Radionuclide imaging in stage B heart failure.
Topics: 3-Iodobenzylguanidine; Asymptomatic Diseases; Cardiomyopathies; Chronic Disease; Coronary Artery Disease; Glucose; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Prognosis; Radionuclide Ventriculography; Radiopharmaceuticals; Sarcoidosis; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2012 |
17 trial(s) available for 3-iodobenzylguanidine and Chronic Disease
| Article | Year |
|---|---|
Phase II study of
Topics: 3-Iodobenzylguanidine; Adolescent; Busulfan; Child; Child, Preschool; Chronic Disease; Humans; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Topotecan; Young Adult | 2023 |
Effect of intramyocardial bone marrow-derived mononuclear cell injection on cardiac sympathetic innervation in patients with chronic myocardial ischemia.
Topics: 3-Iodobenzylguanidine; Analysis of Variance; Bone Marrow Transplantation; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Heart; Humans; Iodine Radioisotopes; Leukocytes, Mononuclear; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Severity of Illness Index; Sympathetic Nervous System; Technetium; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2014 |
¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.
Topics: 3-Iodobenzylguanidine; Chronic Disease; Female; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Liver; Lung; Male; Mediastinum; Middle Aged; Multivariate Analysis; Myocardial Perfusion Imaging; Photons | 2015 |
Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Cheyne-Stokes Respiration; Chronic Disease; Exercise; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Respiration, Artificial; Sympathetic Nervous System | 2017 |
Elevated Heart Rate is Associated with Cardiac Denervation in Patients with Heart Failure: A 123-Iodine-MIBG Myocardial Scintigraphy Study.
Topics: 3-Iodobenzylguanidine; Adult; Cardiovascular Agents; Chronic Disease; Denervation; Exercise Test; Female; Heart; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Radionuclide Imaging; Sympathetic Nervous System | 2016 |
Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Cross-Over Studies; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides | 2011 |
Clinical implications of cardiac (123)I-meta-iodobenzylguanidine scintigraphy and cardiac natriuretic peptides in patients with heart disease.
Topics: 3-Iodobenzylguanidine; Angina Pectoris; Atrial Natriuretic Factor; Cardiomyopathies; Chronic Disease; Female; Follow-Up Studies; Heart Diseases; Heart Valve Diseases; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2002 |
Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Ventricular Function, Left | 2003 |
Correlation between cardiac norepinephrine overflow during exercise and cardiac 123I-MIBG uptake in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Chronic Disease; Exercise Test; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Rest; Statistics as Topic; Ventricular Dysfunction, Left | 2003 |
Dynamic 123I-MIBG SPECT reflects sympathetic nervous integrity and predicts clinical outcome in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Cardiotonic Agents; Chronic Disease; Disease-Free Survival; Female; Heart Failure; Humans; Image Interpretation, Computer-Assisted; Japan; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Severity of Illness Index; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasodilator Agents | 2004 |
Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure: comparison with enalapril.
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Enalapril; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Perindopril; Radionuclide Imaging; Risk Factors; Stroke Volume; Sympathetic Nervous System; Treatment Outcome | 2008 |
Impact of exercise rehabilitation on cardiac neuronal function in heart failure: an iodine-123 metaiodobenzylguanidine scintigraphy study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Chronic Disease; Exercise Therapy; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Neurons; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Function, Left | 1998 |
Cardiac sympathetic nervous disintegrity is related to exercise intolerance in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Blood Pressure; Chronic Disease; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 1998 |
Long-term effects of the angiotensin-converting enzyme inhibitor enalapril on chronic heart failure. Examination by 123I-MIBG imaging.
Topics: 3-Iodobenzylguanidine; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrillation; Chronic Disease; Enalapril; Female; Heart Failure; Humans; Hypertension; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Ventricular Function, Left | 1998 |
Cardiac adrenergic innervation within the first 3 months after acute myocardial infarction.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Adult; Aged; Chronic Disease; Electrocardiography; Follow-Up Studies; Heart; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Muscle Denervation; Myocardial Infarction; Myocardial Reperfusion; Technetium Tc 99m Sestamibi; Thrombolytic Therapy; Time; Tomography, Emission-Computed, Single-Photon | 2000 |
Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Atrial Natriuretic Factor; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Female; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Propanolamines; Therapeutic Equivalency; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2001 |
Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Dilated; Chronic Disease; Female; Humans; Hypertrophy, Left Ventricular; Lung; Male; Middle Aged; Myocardial Ischemia; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Ultrasonography | 2001 |
27 other study(ies) available for 3-iodobenzylguanidine and Chronic Disease
| Article | Year |
|---|---|
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to
Topics: 3-Iodobenzylguanidine; Chronic Disease; Humans; N-Myc Proto-Oncogene Protein; Neoplasm Recurrence, Local; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Vesicular Monoamine Transport Proteins | 2024 |
Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Prognosis; Prospective Studies; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2019 |
Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Area Under Curve; Cause of Death; Chronic Disease; Cohort Studies; Disease-Free Survival; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; ROC Curve; Survival Analysis | 2018 |
Role of cardiac
Topics: 3-Iodobenzylguanidine; Aged; Arrhythmias, Cardiac; Chronic Disease; Defibrillators, Implantable; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Observer Variation; Prospective Studies; Radionuclide Imaging; Secondary Prevention; Tomography, Emission-Computed, Single-Photon | 2019 |
Incremental prognostic value of myocardial neuroadrenergic damage in patients with chronic congestive heart failure: An iodine-123 meta-iodobenzylguanidine scintigraphy study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Defibrillators, Implantable; Female; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Risk Assessment | 2020 |
Prediction of sudden cardiac death in chronic heart failure patients with reduced ejection fraction by ADMIRE-HF risk score and early repolarization pattern.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Electrocardiography; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardium; Prevalence; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk; Risk Assessment; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2020 |
Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching.
Topics: 3-Iodobenzylguanidine; Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Death; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nicorandil; Organ Size; Prognosis; Radionuclide Imaging; Sympathetic Nervous System | 2014 |
A prediction model for 5-year cardiac mortality in patients with chronic heart failure using ¹²³I-metaiodobenzylguanidine imaging.
Topics: 3-Iodobenzylguanidine; Analysis of Variance; Chronic Disease; Death; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Radionuclide Imaging; Risk | 2014 |
Serial ¹²³I-metaiodobenzylguanidine imaging predicts the risk of sudden cardiac death in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Survival Rate | 2015 |
Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.
Topics: 3-Iodobenzylguanidine; Chronic Disease; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk; Ventricular Dysfunction, Left | 2015 |
Creation of mortality risk charts using 123I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: 2- and 5-year risk models.
Topics: 3-Iodobenzylguanidine; Aged; Cause of Death; Chronic Disease; Cohort Studies; Databases, Factual; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; ROC Curve; Survival Analysis; Time Factors | 2016 |
Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with si
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Female; Heart Failure, Systolic; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2009 |
123I-meta-iodobenzylguanidine in patients with chronic heart failure: technical aspects, conceptual issues, and future prospects.
Topics: 3-Iodobenzylguanidine; Chronic Disease; Heart Failure; Humans; Prognosis; Radionuclide Imaging | 2009 |
Spatial inhomogeneity of sympathetic nerve function in hibernating myocardium.
Topics: 3-Iodobenzylguanidine; Animals; Chronic Disease; Coronary Circulation; Coronary Stenosis; Death, Sudden, Cardiac; Disease Models, Animal; Heart; Iodine Radioisotopes; Myocardial Stunning; Norepinephrine; Swine; Sympathetic Nervous System; Tissue Distribution | 2002 |
Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Cardiomyopathy, Dilated; Chronic Disease; Female; Heart Failure; Heart Rate; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Ischemia; Myocardium; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric | 2005 |
123I- Metaiodobenzylguanidine in chronic heart failure: Is there a clinical use?
Topics: 3-Iodobenzylguanidine; Chronic Disease; Heart Failure; Humans; Metabolic Clearance Rate; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2006 |
Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Disease-Free Survival; Electrocardiography, Ambulatory; Female; Heart Failure; Humans; Male; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2007 |
Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Coronary Artery Disease; Europe; Heart; Heart Failure; Humans; Mediastinum; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Comorbidity; Female; Heart Failure; Humans; Incidence; Japan; Male; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stroke Volume; Survival Analysis; Survival Rate; Ventricular Dysfunction, Left | 2008 |
Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content.
Topics: 3-Iodobenzylguanidine; Acute Disease; Animals; Chronic Disease; Dogs; Electrocardiography; Heart; Image Processing, Computer-Assisted; Iodine Radioisotopes; Iodobenzenes; Microscopy, Fluorescence; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Norepinephrine; Radionuclide Imaging; Sympathetic Nervous System; Sympathomimetics | 1995 |
Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Enalapril; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardium; Norepinephrine; Prospective Studies; Sympatholytics; Tomography, Emission-Computed, Single-Photon | 1996 |
[Congenital cyanotic heart disease and peripheral neurogenic tumor].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Chronic Disease; Dextrocardia; Epilepsy, Tonic-Clonic; Fatal Outcome; Heart Defects, Congenital; Humans; Hypertension; Hypertension, Renovascular; Hypoxia; Male; Metanephrine; Paraganglioma; Pentetic Acid; Pulmonary Edema; Renal Artery; Situs Inversus; Tomography, Emission-Computed, Single-Photon | 1999 |
Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Chronic Disease; Exercise Test; Exercise Tolerance; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardium; Oxygen Consumption; Prognosis; Prospective Studies; Radionuclide Ventriculography; Radiopharmaceuticals; ROC Curve; Severity of Illness Index | 1999 |
Heterogeneous cardiac sympathetic innervation in heart failure after myocardial infarction of rats.
Topics: 3-Iodobenzylguanidine; Animals; Blood Pressure; Chronic Disease; Heart; Heart Failure; Iodine Radioisotopes; Iodocyanopindolol; Male; Myocardial Infarction; Myocardium; Norepinephrine; Organ Size; Radionuclide Imaging; Rats; Rats, Wistar; Receptors, Adrenergic; Sympathetic Nervous System; Tissue Distribution; Ventricular Remodeling | 2000 |
[Assessment of cardiac sympathetic nerve activity in children with chronic heart failure using quantitative iodine-123 metaiodobenzylguanidine imaging].
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Chronic Disease; Female; Heart; Heart Failure; Humans; Infant; Male; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Sympathetic Nervous System | 2000 |
Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Ventricular Dysfunction, Left | 2001 |
Relationship between cardiac metaiodobenzylguanidine uptake and hemodynamic, functional and neurohormonal parameters in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Disease Progression; Exercise Test; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Oxygen Consumption; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume | 2001 |